Torque'S Montor-Bl Tablets

Torque’s Montor BL Tablets contain Bilastine, a second-generation H1-antihistamine and Montelukast, which is a leukotriene receptor antagonist.

Pharmaceutical Dosage Form:

Tablet

Route of Administration:

Oral

Composition:

Each film-coated tablet contains:

Bilastine I.P. 20 mg
Montelukast Sodium eq. to Montelukast I.P. 10 mg
Excipients q.s.

Mechanism of Action:

Bilastine is a non-sedating, long-acting histamine antagonist with selective peripheral H1 receptor antagonist affinity and no affinity for muscarinic receptors. Montelukast is an orally active compound that binds with high affinity and selectivity to the CysLT1 receptor. CysLT (cysteinyl leukotriene: LTC4, LTD4, LTE4) receptors have been correlated with the pathophysiology of asthma and allergic rhinitis

Indications:

Torque’s Montor BL Tablets are indicated for the treatment of allergic rhinitis (Perennial and Seasonal).

Dosage:

As directed by the physician.

Storage:

Store at a temperature not exceeding 30°C, protect from light & moisture

Presentation:

10 x 1 x 10 Tablets

Side effects:

Headache, Allergic conjunctivitis, Abdominal pain/upper abdominal pain, Drowsiness

Contraindications:

Torque’s Montor BL Tablets are contraindicated in patients with known hypersensitivity to the active substance or to any of the excipients.

Drug Interactions:

Ketoconazole, Erythromycin, Diltiazem, Lorazepam, Theophylline, Prednisolone, Terfenadine, Digoxin, Warfarin

GLOBAL HORIZONS

Your Efforts Extended Through a Partnership That's Better Together

Become a Dealer